Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
2.570
+0.050 (1.98%)
At close: Feb 13, 2026, 4:00 PM EST
2.572
+0.002 (0.08%)
After-hours: Feb 13, 2026, 7:52 PM EST
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $1.02 billion as of February 13, 2026. Its market cap has decreased by -44.85% in one year.
Market Cap
1.02B
Enterprise Value
771.90M
1-Year Change
-44.85%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $1.02B, an increase of 317.09%. That is a compound annual growth rate of 13.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.00B | -7.69% |
| Dec 31, 2025 | 1.08B | -51.95% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.10B |
| Pharming Group | 1.08B |
| EyePoint | 1.07B |
| Geron | 1.05B |
| Vir Biotechnology | 1.04B |
| Sana Biotechnology | 1.03B |
| Ventyx Biosciences | 1.00B |
| Evommune | 995.22M |